FI894397A - Menetelmä terapeuttisesti aktiivisten nukleosidijohdannaisten estereiden ja amidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten nukleosidijohdannaisten estereiden ja amidien valmistamiseksi Download PDF

Info

Publication number
FI894397A
FI894397A FI894397A FI894397A FI894397A FI 894397 A FI894397 A FI 894397A FI 894397 A FI894397 A FI 894397A FI 894397 A FI894397 A FI 894397A FI 894397 A FI894397 A FI 894397A
Authority
FI
Finland
Prior art keywords
group
amides
esters
preparation
therapeutically active
Prior art date
Application number
FI894397A
Other languages
English (en)
Swedish (sv)
Other versions
FI93217B (fi
FI894397A0 (fi
FI93217C (fi
Inventor
Jo Klaveness
Frode Rise
Kjell Undheim
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878706991A external-priority patent/GB8706991D0/en
Priority claimed from GB878713464A external-priority patent/GB8713464D0/en
Application filed by Nycomed As filed Critical Nycomed As
Publication of FI894397A0 publication Critical patent/FI894397A0/fi
Publication of FI894397A publication Critical patent/FI894397A/fi
Publication of FI93217B publication Critical patent/FI93217B/fi
Application granted granted Critical
Publication of FI93217C publication Critical patent/FI93217C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
FI894397A 1987-03-24 1989-09-18 Menetelmä terapeuttisesti aktiivisten nukleosidijohdannaisten estereiden ja amidien valmistamiseksi FI93217C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB878706991A GB8706991D0 (en) 1987-03-24 1987-03-24 Chemical compounds
GB8706991 1987-03-24
GB878713464A GB8713464D0 (en) 1987-06-09 1987-06-09 Chemical compounds
GB8713464 1987-06-09
GB8800224 1988-01-06
PCT/GB1988/000224 WO1988007532A1 (en) 1987-03-24 1988-03-23 2',3' dideoxyribofuranoxide derivatives

Publications (4)

Publication Number Publication Date
FI894397A0 FI894397A0 (fi) 1989-09-18
FI894397A true FI894397A (fi) 1989-09-18
FI93217B FI93217B (fi) 1994-11-30
FI93217C FI93217C (fi) 1995-03-10

Family

ID=26292055

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894397A FI93217C (fi) 1987-03-24 1989-09-18 Menetelmä terapeuttisesti aktiivisten nukleosidijohdannaisten estereiden ja amidien valmistamiseksi

Country Status (9)

Country Link
EP (1) EP0342203B1 (fi)
JP (1) JPH02503312A (fi)
AT (1) ATE108183T1 (fi)
AU (1) AU613026B2 (fi)
DE (1) DE3850571T2 (fi)
FI (1) FI93217C (fi)
NZ (1) NZ223990A (fi)
OA (1) OA09242A (fi)
WO (1) WO1988007532A1 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
NZ223910A (en) * 1987-03-20 1991-02-26 Bristol Myers Co 2',3'-dideoxynucleosides, process for their production and intermediates therefor
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
ZA886890B (en) * 1987-10-09 1989-05-30 Hoffmann La Roche Novel dideoxycytidine derivatives
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
JPH02164881A (ja) * 1988-10-24 1990-06-25 Wellcome Found Ltd:The 治療用ヌクレオシド化合物
US5164520A (en) * 1989-04-24 1992-11-17 E. R. Squibb & Sons, Inc. Intermediates for purinyl and pyrimidinyl tetrahydrofurans
NZ232993A (en) * 1989-04-24 1992-10-28 Squibb & Sons Inc Purinyl and pyrimidinyl tetrahydrofurans
US5059690A (en) * 1990-03-01 1991-10-22 E. R. Squibb & Sons, Inc. Purinyl tetrahydrofurans
US5145960A (en) * 1989-04-24 1992-09-08 E. R. Squibb & Sons, Inc. Pyrimidinyl tetrahydrofurans
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
JPH05501404A (ja) * 1989-11-06 1993-03-18 ニユコメド・アクシエセルカペト ヌクレオシド誘導体
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5914331A (en) * 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5827727A (en) 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US6703396B1 (en) 1990-02-01 2004-03-09 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
CA2079796A1 (en) * 1990-04-04 1991-10-05 Jo Klaveness Nucleoside derivatives
GB9007569D0 (en) * 1990-04-04 1990-05-30 Nycomed As Carbo-nucleoside derivatives
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
ES2067395B1 (es) * 1993-03-10 1996-01-01 Norsk Hydro As Derivados de nucleosidos o analogos a nucleosidos.
WO1995007086A1 (en) * 1993-09-10 1995-03-16 Emory University Nucleosides with anti-hepatitis b virus activity
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
DE69636734T2 (de) 1995-06-07 2007-10-18 Emory University Nucleoside mit anti-hepatitis b virus wirksamkeit
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
US6436948B1 (en) 2000-03-03 2002-08-20 University Of Georgia Research Foundation Inc. Method for the treatment of psoriasis and genital warts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
EP0206497B1 (en) * 1985-05-15 1994-07-20 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
GB8712691D0 (en) * 1987-05-29 1987-07-01 Wellcome Found Therapeutic nucleosides
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
ATE108183T1 (de) 1994-07-15
NZ223990A (en) 1990-08-28
FI93217B (fi) 1994-11-30
EP0342203A1 (en) 1989-11-23
FI894397A0 (fi) 1989-09-18
FI93217C (fi) 1995-03-10
DE3850571D1 (de) 1994-08-11
EP0342203B1 (en) 1994-07-06
OA09242A (en) 1992-06-30
AU1489388A (en) 1988-11-02
JPH02503312A (ja) 1990-10-11
DE3850571T2 (de) 1994-10-27
AU613026B2 (en) 1991-07-25
WO1988007532A1 (en) 1988-10-06

Similar Documents

Publication Publication Date Title
FI894397A (fi) Menetelmä terapeuttisesti aktiivisten nukleosidijohdannaisten estereiden ja amidien valmistamiseksi
NO180541C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 9-purinylfosfonsyrederivater og mellomprodukt for fremstilling derav
KR930019213A (ko) 간염치료에 유용한 1,3-옥사티올란류
MY114350A (en) Antiviral activity and resolution of 2-hydroxymethyl-5- (5-fluorocytosin-1-yl)-1,3-oxathiolane.
ATE313550T1 (de) Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus
SE8802687D0 (sv) Nucleoside derivatives
AU4690989A (en) Antiviral cytosine and guanine derivatives
BR9506596A (pt) Composto l-nucleosídeo e processo para tratamento de ser humano infectado com hbv ou ebv
CA2268703A1 (en) Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity
FI885980A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten purinyyli- ja pyrimidinyylisyklobutaanijohdannaisten valmistamiseksi
PT1153924E (pt) 1,3-oxatiolanos substituidos com propriedades anti-virais
DK297483A (da) Fremgangsmaade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl)guanin
UA41296C2 (uk) Складні ефіри нуклеозиду та його похідні, фармацевтична композиція на їх основі
DE3875769D1 (de) Therapeutische nukleoside.
BG95145A (bg) Метод за получаване на 9-заместени гуанинови производни
NO176052C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive nukleosidderivater
HUP9903632A2 (hu) Neuraminsav vegyületek, azokat tartalmazó gyógyszerkészítmények és eljárás e készítmények előállítására
ES8501416A1 (es) 5'-alquil o alquenil-fosfatos de nucleosidos.
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
AU6101390A (en) Substituted purines for use in the treatment of viruses
ES2067395A1 (es) Derivados de nucleosidos o analogos a nucleosidos.
PT94243A (pt) Processo para preparacao de inibidores beta-lactamicos de elastase
FI863729A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3'-atsido nukleosidien valmistamiseksi

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: NYCOMED IMAGING AS

BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: NYCOMED IMAGING A S